Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosis

Journal of Immunology

Volumn 166, Issue 3, 2001, Pages 2116-2121

  McFarland, H L ^a   Lobito, A A ^a   Johnson, M M ^a   Palardy, G R ^a   Yee, C S K ^a   Jordan, E K ^a   Frank, J A ^a   Tresser, N ^a   Genain, C P ^a   Mueller, J P ^a   Matis, L A ^a   Lenardo, M J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; EPITOPE; MP4 PROTEIN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE EXACERBATION; IMMUNOTHERAPY; MALE; MARMOSET; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0035253746     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.3.2116     Document Type: Article

References (43)

1. Immunology
2. Immunological aspects of demyelinating disease
3. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants
4. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys
5. Remyelination in demyelinating disease
6. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease
7. Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis
8. Creation of a model for multiple sclerosis in Callithrix jacchus marmosets
9. Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis
10. Frequency of T cells specific for myelin base protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis
11. Increased frequency of intedeukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis
12. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ
13. Interleukin-2 programs mouse α/βT lymphocytes for apoptosis
14. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
15. Induction of apoptosis in mature T cells by tumor necrosis factor
16. Autocrine feedback death and the regulation of mature T lymphocyte antigen responses
17. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death
18. Intravenous antigen administration as a therapy for autoimmune demyelinating disease
19. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein
20. Purification of immunologically active recombinant 21.5 kDa isoform of human myelin basic protein
21. Immune tolerance mediated by recombinant proteolipid protein prevents experimental autoimmune encephalomyelitis
22. Spreading of T cell autoimmunity to cryptic determinants of an autoantigen
23. Epitope spreading
24. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis
25. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: A basis for peptide-specific therapy after onset of clinical disease
26. Diversity and plasticity of self recognition during the development of multiple sclerosis
27. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens
28. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide
29. Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis
30. Chronic experimental allergic encephalomyelitis in monkeys
31. Chronic experimental allergic encephalomyelitis in rhesus monkeys and its modification by treatment
32. Suppression of the immune response: Reversal of the disease state with antigen in allergic encephalomyelitis
33. Serial MR imaging of experimental autoimmune encephalomyelitis induced by human white matter or by chimeric myelin-basic and proteolipid protein in the common marmoset
34. Late complications of immune deviation therapy in a nonhuman primate
35. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice
36. Antibody facilitation of multiple sclerosis-like lesions in a non human primate
37. Expression of the interferon-γ and interleukin-10 genes in rabbit HTLV-l-transformed T-cell lines
38. Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus)
39. Identification of autoantibodies associated with myelin damage in multiple sclerosis
40. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system
41. Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis
42. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production
43. Multiple sclerosis: A serial study using MRI in relapsing patients